Boothbay Fund Management’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Boothbay Fund Management’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$201K	Hold	189,899	–	–	﹤0.01%	1779
2025 Q4	$296K	Hold	189,899	–	–	﹤0.01%	1434
2025 Q3	$218K	Hold	189,899	–	–	﹤0.01%	1611
2025 Q2	$182K	Hold	189,899	–	–	﹤0.01%	1258
2025 Q1	$176K	Hold	189,899	–	–	﹤0.01%	1185
2024 Q4	$228K	Hold	189,899	–	–	0.01%	1169
2024 Q3	$220K	Hold	189,899	–	–	0.01%	1374
2024 Q2	$199K	Hold	189,899	–	–	﹤0.01%	1292
2024 Q1	$235K	Hold	189,899	–	–	﹤0.01%	1286
2023 Q4	$211K	Buy	+189,899	New	+$14.8K	0.01%	1317
2023 Q3	–	Sell	-201,800	Closed	-$2.19M	–	1829
2023 Q2	$2.19M	Hold	201,800	–	–	0.05%	524
2023 Q1	$2.14M	Hold	201,800	–	–	0.04%	630
2022 Q4	$2.08M	Hold	201,800	–	–	0.05%	583
2022 Q3	$2.03M	Hold	201,800	–	–	0.05%	566
2022 Q2	$2.02M	Hold	201,800	–	–	0.05%	544
2022 Q1	$2.02M	Hold	201,800	–	–	0.05%	581
2021 Q4	$2M	Buy	201,800 +6,800	+3%	+$3.35K	0.05%	487
2021 Q3	$1.93M	Buy	+195,000	New	+$80K	0.05%	460

Other funds holding ESLAW

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Boothbay Fund Management's ESLAW Position: Q1 2026 in Review

Boothbay Fund Management held its Estrella Immunopharma Warrant (ESLAW) position steady in Q1 2026 at 189,899 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #1779.

Boothbay Fund Management first reported a position in ESLAW in Q3 2021 and has held it in 18 quarters since. The position peaked at $2.19M in Q2 2023. 8 funds tracked by Wall St. Rank hold ESLAW as of Q1 2026.

Boothbay Fund Management held 189,899 shares of Estrella Immunopharma Warrant worth $201K as of Q1 2026.
Boothbay Fund Management left its Estrella Immunopharma Warrant share count unchanged in Q1 2026.
Estrella Immunopharma Warrant made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1779 holding.
Boothbay Fund Management first reported a position in Estrella Immunopharma Warrant in Q3 2021 and has held it in 18 quarters since.
Boothbay Fund Management's Estrella Immunopharma Warrant position peaked at $2.19M in Q2 2023.
8 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.